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The aims of this study were to test the construct validity of the Diabetes Management Self-Efficacy Scale
(DMSES) among Thai patients with Type 2 Diabetes Mellitus. This methodological study consisted of two stages:
(1) Search for existing literature regarding (DMSES) in English to be translated into Thai and further examined
for face validity; and (2) explore the factor structure of the resultant instrument and examine its reliability. A self-
administered questionnaire was used to collect the data in Thai T2DM patients in February 2016. The finding
showed that the Thai Diabetes Management Self-Efficacy scale (T-DMSES) contained four domains with 20
items on self-efficacy: (1) Diet; (2) Monitor; (3) Physical; and (4) Regimen. The scales based on all retained items
showed a high degree of internal consistency (Cronbach’s  = 089). The conclusions of this study revealed
that the T-DMSES contributed to good construct validity. The said questionnaire could be utilized to explore self-
efficacy in Thai T2DM patients, as well as being able to develop and evaluate suitable educational interventions
to enhance self-efficacy. Next study should emphasis on further validating the T-DMSES, including assessing
construct and criterion-based validity, or examining the psychometric properties by utilizing the Confirmatory
Factor Analysis.
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1. INTRODUCTION
Diabetes is considered one of key global public health issues.
The estimated number of people with diabetes worldwide was
285 million cases in 2010 and is projected to reach 439 mil-
lion cases in 2030, the majority of which (69%) are found in
developing countries.1 The number of patients with diabetes in
Asia was estimated at 113 million cases in 2010 and will reach
180 million cases in 2030.2 In a low and middle-income country
like Thailand, diabetes represents one of the leading causes of
morbidity and mortality.3 Currently, there are 3.2 million patients
with diabetes in Thailand, and this is estimated to rise by 1.1 mil-
lion patients in 2035.4
Diabetes mellitus type 2 (T2DM) is a disease where patients
self-care can substantially reduce the risk, or delay the onset,
of T2DM complication. The following tasks can substantially
make the improvement of diabetes: Taking medications as pre-
scribed; monitoring diet and blood glucose levels; perform-
ing physical activities, and caring for feet.5 All of these tasks
come as a package after being diagnosed with diabetes. Such
∗Author to whom correspondence should be addressed.
activities needed to be incorporated into daily living and created
as behaviors so that patients could control the disease and slow
progression and reduce complications.6 The process as men-
tioned above is defined as Diabetes Self-Management (DSM).
The Diabetes Self-Management (DSM) provides support for
informed decision-making, self-care behaviors, problem-solving,
and active collaboration with the health care team, resulting in
improved clinical outcomes, health status, and quality of life.7
The management relies on the long-term cooperation of patients
in obtaining regular medical care and adhering to treatment
plans.8–10
Self-efficacy is referred to as an individual’s perceptions or
beliefs in their capabilities to carry out certain activities.11 It is
influential to their thinking, feeling, motivation, and behaviors.
The person, whose high self-efficacy chooses to perform more
challenging tasks, they set higher goals for themselves and adhere
to the goals. To take action, individuals who have high self-
efficacy exert more effort with more persistence than those who
have low self-efficacy. In a case of setbacks, they achieve quicker
recovery and continue the commitment to achieving their goals.
This efficacious outlook contributes to personal accomplishments,
stress reduction, as well as mitigates vulnerability to depression.12
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The Diabetes Management Self-Efficacy Scale (DMSES) was
originally developed for use in western populations and assesses
the confidence of diabetes patients in their ability to manage
their diet, blood sugar, and physical exercise.13 This instrument
is primarily utilized to measure self-efficacy. From the past to
present, the tool has been widely recognized, adapted, and trans-
lated to be correctly used in several areas with the different cul-
ture, namely, Netherlands,13 the United Kingdom,14 Australia,9
Turkey,15 Taiwan,16 and Korea.13 However, all related researchers
provided different findings possibly because of the various char-
acteristics in each area and sample size. As a result, the original
version of the instrument is varied from those in other areas as
evidenced by a different number of factors to be generated.1516
Although reported as validated, the methodological approaches
used in the validation studies were often valued inappropriately.
An instrument developed and validated on Western may not be
assumed to be valid in Asian populations. Therefore, to apply the
instrument to patients with T2DM in Thailand, it is quite nec-
essary to confirm whether it is proper to use the instrument in
Thailand. Moreover, based on the literature review, it was found
that the development of DMSE instrument has not been validated.
The diabetes management self-efficacy scale (DMSES) among
Thai population is seen as an important initial step to achieve the
goal of preventive services for patients with T2DM. Therefore,
the objective of this study is of test reliability and validity of the
Thai Diabetes Management Self-Efficacy scale for measurement
in Thailand’s context.
2. MATERIALS AND METHOD
This methodological study consisted of two stages:
(1) Search for existing literature regarding Diabetes Manage-
ment Self-Efficacy Scale (DMSES) in English to be translated
into Thai and further examined for face validity; and
(2) Explore the factor structure of the resultant instrument and
examine its reliability.
Phase 1. Instrument translation and face validity
The Diabetes Management Self-Efficacy Scale (DMSES) was
originally a self-administered scale containing 20 items dis-
tributed across four factors, each of which had a 5-point scale.13
The DMSES items were translated from English into Thai by
a forward and backward translation technique. A forward and
backward translation technique was performed by two forward
and two different backward native bilinguals.17 Every translator
was not accustomed to the content and had no clinical back-
ground. The two bilingual translators, whose native language
was Thai, independently proceeded with the forward translation
from the original version, and then finalized the most accurate
and comprehensible terms by consensus. After that, a bilingual
translator, who had not been exposed to the original version
and the concepts being examined in the questionnaire, translated
the items back to English. After the last two bilingual transla-
tors had completed back-translation into the English version, two
native English translators compared between the English back-
translated version and the original English version. Any evident
discrepancies between the two translated versions were modified.
Then, the back-translation process was carried on until the exam-
iner was satisfied with the language equivalency. The field test for
the Thai Diabetes Management Self-Efficacy Scale (T-DMSES)
was conducted in 20 T2DM patients to assess the translation
quality and the practicality of the test administration. Respon-
dents were asked to read or listen to each item to ensure their
understanding of each item.
Phase 2. Evaluating the psychometric properties of the
T-DMSES
1. Sample and study design
The study was a cross-sectional study design aiming to test
the reliability and validity of the T-DMSES in Thai T2DM
patients. 700 T2DM patients were living in both rural and
urban areas from The Central and Northeastern Thailand. The
T2DM samples were recruited from outpatient diabetes clin-
ics of both community hospitals and University hospitals in
KhonKaen province and Bangkok, Thailand. The development
of stratification was based on locality, while the determina-
tion of sample size was of this study based on factor anal-
ysis to establish construct validity: 100 = fair, 200 = good,
500 = very good, and >1000= excellent.18 The questionnaire
was administered in February–June 2016 to T2DM outpatients
aged ≥20 years old who were diagnosed with T2DM for more
than three years, able to read or understand Thai language
and willing to participate in the study. The authorized per-
son of each hospital gave permission to collect the data, and
all participants provided informed consent. Then, the data of
the participants were collected until the data collection was
completed using the participants’ self-report. The study pro-
tocol was approved by the ethics committee of KhonKaen
University (HE581479), Institutional Review Board at Fac-
ulty of Medicine, Chulalongkorn University (IRB035/59), and
Bangkok Metropolitan Administration Ethics Committee for
Human Research (U005q/59).
2. Demographic and clinical characteristic of DMSES
The original Version of the Diabetes Management Self-
Efficacy Scale (DMSES) was a self-administered scale com-
posed of 20 items designed to investigate behaviors in terms
of four factors as follows:
(1) specific nutrition and weight, with a subscale of five
items designed to determine the stick and adjust to diet
when away from home, stick to diet on vacation and
party, control weight;
(2) general nutrition and medical treatment, with a sub-
scale of nine items designed to determine the choose and
variation in nutrition, stick to diet most of the time, adjust
diet when ill and stress check feet, consult physician for
diabetes control, used of medication;
(3) physical exercise, with a subscale of three items
designed to determine the extra and take care of training
on physician’s advice; and
(4) blood sugar, with a subscale of three items designed
to determine the remedy low and high and self-control
blood sugar.
The items were scored on a 5-point Likert-type scale, with
higher scores indicating higher self-efficacy. From the past to
present, the instrument has been widely recognized, adapted,
and translated to be properly used in several areas with a dif-
ferent culture.9131516
3. Statistical analysis
Demographic data of the participants in this study were sum-
marized using descriptive statistics. Exploratory factor analysis
(EFA) was a method to confirm the construct validity of instru-
ment model to seek a single or set of predefined constructs. EFA
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Table I. Patient characteristics.
Characteristics (n = 700) n (%)
Parts of Hospital
Phuphaman Hospital 60 (8.57)
Srinagarind Hospital 78 (11.14)
Wechkaroonrasm Hospital 242 (34.57)
Chulalongkorn Hospital 320 (45.71)
Gender
Male 208 (29.71)
Female 492 (70.29)
Age (Years)
Mean (SD) 65.16 (10.94)
Range 26–95
Marital Status
Single 57 (8.14)
Married 465 (66.43)
Divorce 165 (23.57)
Separate 13 (1.86)
Education
No formal education 47 (6.71)
Elementary school 381 (54.43)
High school 146 (20.86)
Bachelor degree 99 (14.14)
Master degree 25 (3.57)
Higher degree 2 (0.29)
Religion
Buddhism 543 (77.57)
Islam 152 (21.71)
Christianity 5 (0.71)
Monthly income
<4,999 baht (Less than 143 USD) 318 (45.43)
5,000–9,999 baht (143 to 287 USD) 95 (13.56)
10,000–14,999 baht (287 to 413 USD) 86 (12.29)
15,000–19,999 baht (413 to 575 USD) 48 (6.86)
20,000–24,999 baht (575 to 718 USD) 48 (6.86)
>25,000 baht (more than 718 USD) 105 (15.00)
BMI
<18.5 20 (2.86)
18.5–24.9 279 (39.86)
25–29.9 219 (31.29)
≥30 182 (26)
(Mean = 2708; SD= 632)
Duration of diabetes
≤5 years 85 (12.14)
>5 years 615 (87.86)
(Mean = 1353; SD= 834)
Family history of DM
Yes 370 (52.86)
No 330 (47.14)
Co-morbidity
Hyperlipidemia 605 (86.43)
Hypertension 603 (86.14)
Heart disease 38 (5.43)
Renal disease 188 (26.86)
Treatment of DM
No drug 14 (2)
Oral hyperglycemic agent (OHA) 408 (58.29)
Insulin sensitizer 94 (13.43)
Both OHA and insulin sensitivity 184 (26.29)
Smoking
No 589 (84.14)
Previously 88 (12.57)
Yes 23 (3.29)
Alcohol
No 569 (81.29)
Previously 89 (12.71)
Yes 42 (6)
Hba1c
≤7% 317 (45.29)
>7% 383 (54.71)
(Mean = 7.58; SD= 170)
was used to initially determine the number of latent factors or the
pattern of correlations between the common factors and the indi-
cators. Parallel analysis based on Principal Components Analysis
was used to determine the nature of the underlying factors. An
Oblique (Promax) model was adopted after principal axis fac-
toring models were compared with orthogonal (Varimax) and
oblique rotations. Eigenvalues greater than 1 and factor loading
cut-off of less than 0.2 were used to acquire the best fitting struc-
ture and the accurate number of factors. The R statistics package
by v 2.3.0; R CoreTeam, 2015 was used to conduct all analyses,
and the R library lavaan was utilized to proceed with the com-
plete factor analysis.19 Cronbach’s alpha was used to evaluate the
internal consistency reliability of the overall instrument and the
individual subscales. Acceptable reliability for the scale and all
subscales was designated to be  > 07.20
3. RESULTS AND DISCUSSION
3.1. Demographic Characteristics of Participants in a
Validation Study
There were totally 700 T2DM patients completing the question-
naire (Response rate of 94.3%), with age ranging from 26 to
95 years old (Mean = 6516, SD= 1094). The research partici-
pants consisted of 29.71% males and 70.29% females. They had
been diagnosed with diabetes for 13.53 years on average (SD=
834). Other demographic characteristics of the participants were
presented in Table I.
3.2. Exploratory Factor Analysis (EFA)
According to the exploratory factor analysis in 700 patients, a
parallel group study was conducted, and four-factor structure was
deemed appropriate (Fig. 1). The KMO was 0.88 and Bartlett’s
sphericity test was significant (2 = 8576884, df = 190, p <
0001) indicating reasonable adequacy of the data for factor anal-
ysis. The measurement model for Thai diabetes management self-
efficacy scale (T-DMSES) and 20 items was conducted as shown
in Figure 2. Nevertheless, the authors decided to retain two of the
20 lower loading items since their inclusion was quite strongly
supported by the literature. The principal axis factoring with an
oblique rotation was subsequently utilized to explore the factor
structure, and the resultant loadings are giving in Table II.
3.3. Internal Consistency
Based on the four factor model, the reliability of the T-
DMSES was evaluated for internal consistency (Cronbach’s
Fig. 1. Scree plot for determination of number of factors.
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Fig. 2. Measurement model for Thai diabetes management self-efficacy
scale (T-DMSES).
alpha). The alpha value of 0.89 indicates sufficiently high relia-
bility to provide confidence in interpreting the score.
4. DISCUSSION
To the best of the authors’ knowledge, this is the first time that a
version of the DMSES has been tested for content validity in Thai
T2DM patients. Our instrument provided strong internal consis-
tency reliability. Moreover, it was found that most of the items
Table II. Factor loading of the T-DMSES from principal axis factoring.
Factors Items Diet Monitor Physical Regimen
Diet (9 item)
dmses4 I can choose to eat good and healthy foods that are beneficial to my health 0.77 – – –
dmses5 I can choose to eat various foods to maintain a healthy diet plan 0.79 – – –
dmses9 I can maintain a healthy diet plan in the event that I get sick 0.26 – – –
dmses10 I can follow a healthy diet plan regularly 0.70 – – –
dmses13 I can follow a healthy diet plan even when I am not at home 0.88 – – –
dmses14 I can choose from various foods to maintain a healthy diet plan when I am not at
home
0.95 – – –
dmses15 I can follow a healthy diet plan during festivals, traditions, or rituals 0.93 – – –
dmses16 I can choose to eat various foods to maintain a healthy diet plan when I eat foods at
parties
0.94 – – –
dmses17 I can maintain a healthy diet plan when I am feeling stressed or worried 0.31 – – –
Monitor (4 Items)
dmses1 I can check blood glucose levels by myself if necessary – * – –
dmses2 I can reduce blood glucose levels when glucose levels in my blood are too high (for
example, changing the kinds of foods I eat).
– 0.36 – –
dmses3 I can increase blood glucose levels when glucose levels in my blood are too low (for
example, changing the kinds of foods I eat)
– * – –
dmses7 I can attend to my feet (for example, cutting toe nails and taking care of myself not
causing wounds).
– 0.21 – –
Physical (4 Items)
dmses6 I can control my body weight and maintain appropriate weight ranges – – 0.28 –
dmses8 I can exercise and perform sufficient physical activity (for example, walking, aerobic
dancing, muscle exercise, etc.)
– – 0.67 –
dmses11 I can increase the amount that I exercise if a doctor advises me to do so – – 0.88 –
dmses12 In the case that I exercise more, I can modify my healthy diet plan – – 0.82 –
Regimen (3 Items)
dmses18 I can schedule an appointment to see a doctor four times a year to check my
diabetes
– – – 0.43
dmses19 I can take medicines as prescribed by a doctor – – – 0.89
dmses20 I can keep taking medicines continuously when I am sick – – – 0.70
Note: ∗Low loading items forced into model.
strongly aligned with their hypothesized constructs, and enabled
researchers and practitioners to gain a better understanding of self-
efficacy for seeking interventions. Based on the findings of our
study, the T-DMSES revealed that relevant underlying domains
for the evaluation of self-efficacy included Diet, Monitor, Phys-
ical, and Regimen. Some domains of the T-DMSES were con-
sistent with those identified in previous studies.16 To conduct the
exploratory factor analysis, the authors chose the method of prin-
cipal axis factoring with oblique rotation to extract factors. The
results of such analysis suggested that there were 2 items from
an original version of measurement with factor loading <0.2, but
they were likely to be associated with self-efficacy in Thai T2DM
patients. Therefore, we decided to force two of these 20 items into
the model, and see if they should still be excluded in a subsequent
confirmatory factor analysis. In particular, blood glucose levels
could be checked by myself if necessary, as well as being able to
increase blood glucose levels when glucose levels in my blood are
too low. Our research had some limitations. First, we considered
recruiting T2DM patients from only the Central and Northeast-
ern part of Thailand. The representativeness of this sample for all
Thai T2DM patients was not possible. Second, regarding the val-
idation process, T-DMSES had not yet undergone a construct or
criterion-based validation at this stage. Even now, there was no
evidence that this instrument could either discriminate between
T2DM patients who achieved blood sugar levels and those who
could not achieve blood sugar levels, or be used to evaluate the
efficiency of a program to enhance self-management (predictive
validity). Nonetheless, this study also had some major strength.
First, our validation of T-DMSES is the most comprehensive
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evaluation of psychometric properties of the DMSES instrument
ever conducted in any population. Our study was multi-center and
captured the full spectrum of healthcare available in Thailand. In
contrast, all previous studies attempting to validate DMSES have
used samples of between 88 to 440 patients invariably collected
from a single site. Our study applied an appropriate exploratory
factor analysis, i.e., principal axis factoring, to identifying the
domains underlying the T-DMSES, and we planned to conduct
Confirmatory Factor Analysis and criterion-based validation in
our next study. On the contrary, the most commonly used instru-
ment for evaluating diabetes management self-efficacy, DMSES,13
was structured in such a way as to cause difficulties in full psy-
chometric validation.
5. CONCLUSION
The T-DMSES contributed to good psychometric regarding con-
struct validity and internal consistency reliability, suggesting its
utility in evaluating self-efficacy in Thai T2DM patients. In the
future, T-DMSES would be likely to provide valuable insights
into the epidemiology of diabetes management self-efficacy, and
may also be used to assess interventions to reduce ineffective
self-care in T2DM patients. In turn, this would potentially reduce
the incidence and mortality of patients with type 2 diabetes mel-
litus complications.
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